Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Big Pharma
Pharmaceutical company Sanofi has been granted a stay by the US Supreme Court in its ongoing patent litigation battle with Netherlands-based Mylan.   13 February 2020
Big Pharma
Ahead of the Global IP Exchange Europe on March 9-11 in Berlin, the event’s organisers surveyed senior executives to find out their IP, patent, trademark, and brand protection investment priorities for the next 6-12 months.   13 February 2020
Americas
American Regent, the US subsidiary of pharmaceutical company Daiichi Sankyo, has taken iron therapy specialist Pharmacosmos to court over an injectable treatment for anaemia.   12 February 2020
Americas
A Utah jury has found a former Becton Dickinson research engineer not guilty of stealing trade secrets covering the medical device company’s antiseptic products.   12 February 2020
Big Pharma
Clarivate Analytics has released its annual “drug to watch” list, compiled through its Cortellis database of life sciences-focused research and development data.   11 February 2020
Europe
In a victory for the University of California, the European Patent Office has affirmed a CRISPR patent issued to Emmanuelle Charpentier, the University of California, and the University of Vienna.   11 February 2020
Europe
Gareth Probert, the former head of HGF’s Nottingham, UK office, has joined EIP to strengthen its medtech and healthcare practice.   11 February 2020
Big Pharma
The US embassy in the Netherlands has expressed its concern about the Dutch government’s plans to “undermine” IP rights for medicines.   11 February 2020
Europe
The UK Intellectual Property Office has blocked Canadian brand Vivo Cannabis from registering ‘Lumina’ as a trademark, after an opposition from an Italian pharmaceutical company.   7 February 2020
Big Pharma
US multinational biotechnology company Biogen has successfully defended multiple sclerosis treatment Tecfidera from a patent challenge brought by generic and specialty pharma company Mylan.   6 February 2020